Pure Bioscience's total assets for Q1 2024 were $2.25M, an increase of 23.36% from the previous quarter. PURE total liabilities were $2.63M for the fiscal quarter, a 362.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.